These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 8981683)

  • 1. Borrowing strength from external trials in a meta-analysis.
    Higgins JP; Whitehead A
    Stat Med; 1996 Dec; 15(24):2733-49. PubMed ID: 8981683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Meta-analysis of the Italian studies on short-term effects of air pollution].
    Biggeri A; Bellini P; Terracini B;
    Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-blockers for the prevention of variceal haemorrhage in patients with cirrhosis: an updated meta-analysis of randomized controlled trials.
    Ricca Rosellini S; Miglio F
    Ital J Gastroenterol; 1991; 23(7):408-15. PubMed ID: 1683803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of continuous outcome data from individual patients.
    Higgins JP; Whitehead A; Turner RM; Omar RZ; Thompson SG
    Stat Med; 2001 Aug; 20(15):2219-41. PubMed ID: 11468761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bayesian random effects meta-analysis of trials with binary outcomes: methods for the absolute risk difference and relative risk scales.
    O'Rourke K; Altman DG
    Stat Med; 2005 Sep; 24(17):2733-42; author reply 2743. PubMed ID: 16118810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of ordinal outcomes using individual patient data.
    Whitehead A; Omar RZ; Higgins JP; Savaluny E; Turner RM; Thompson SG
    Stat Med; 2001 Aug; 20(15):2243-60. PubMed ID: 11468762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of underlying risk as a source of heterogeneity in meta-analyses: a simulation study of Bayesian and frequentist implementations of three models.
    Dohoo I; Stryhn H; Sanchez J
    Prev Vet Med; 2007 Sep; 81(1-3):38-55. PubMed ID: 17477995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian random effects meta-analysis of trials with binary outcomes: methods for the absolute risk difference and relative risk scales.
    Warn DE; Thompson SG; Spiegelhalter DJ
    Stat Med; 2002 Jun; 21(11):1601-23. PubMed ID: 12111922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Random effects survival models gave a better understanding of heterogeneity in individual patient data meta-analyses.
    Michiels S; Baujat B; Mahé C; Sargent DJ; Pignon JP
    J Clin Epidemiol; 2005 Mar; 58(3):238-45. PubMed ID: 15718112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-adrenergic antagonists in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysis.
    Bernard B; Lebrec D; Mathurin P; Opolon P; Poynard T
    Hepatology; 1997 Jan; 25(1):63-70. PubMed ID: 8985266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Random effects meta-analysis of event outcome in the framework of the generalized linear mixed model with applications in sparse data.
    Stijnen T; Hamza TH; Ozdemir P
    Stat Med; 2010 Dec; 29(29):3046-67. PubMed ID: 20827667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mixtures of prior distributions for predictive Bayesian sample size calculations in clinical trials.
    Brutti P; De Santis F; Gubbiotti S
    Stat Med; 2009 Jul; 28(17):2185-201. PubMed ID: 19462415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension. American College of Gastroenterology Practice Parameters Committee.
    Grace ND
    Am J Gastroenterol; 1997 Jul; 92(7):1081-91. PubMed ID: 9219775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quasi-empirical Bayes methodology for improving meta-analysis.
    Saleh AK; Hassanein KM; Hassanein RS; Kim HM
    J Biopharm Stat; 2006; 16(1):77-90. PubMed ID: 16440838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applying the law of iterated logarithm to control type I error in cumulative meta-analysis of binary outcomes.
    Hu M; Cappelleri JC; Lan KK
    Clin Trials; 2007; 4(4):329-40. PubMed ID: 17848494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of three different models for estimating relative risk in meta-analysis of clinical trials under unobserved heterogeneity.
    Kuhnert R; Böhning D
    Stat Med; 2007 May; 26(11):2277-96. PubMed ID: 16991109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-regression detected associations between heterogeneous treatment effects and study-level, but not patient-level, factors.
    Schmid CH; Stark PC; Berlin JA; Landais P; Lau J
    J Clin Epidemiol; 2004 Jul; 57(7):683-97. PubMed ID: 15358396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating trial and treatment heterogeneity in an individual patient data meta-analysis of survival data by means of the penalized maximum likelihood approach.
    Rondeau V; Michiels S; Liquet B; Pignon JP
    Stat Med; 2008 May; 27(11):1894-910. PubMed ID: 18069745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does tight heart rate control improve beta-blocker efficacy? An updated analysis of the noncardiac surgical randomized trials.
    Beattie WS; Wijeysundera DN; Karkouti K; McCluskey S; Tait G
    Anesth Analg; 2008 Apr; 106(4):1039-48, table of contents. PubMed ID: 18349171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials.
    Wijeysundera DN; Austin PC; Hux JE; Beattie WS; Laupacis A
    J Clin Epidemiol; 2009 Jan; 62(1):13-21.e5. PubMed ID: 18947971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.